Model Answer
0 min readIntroduction
"Monday morning sickness," formally known as equine recurrent uveitis (ERU), is a chronic, relapsing inflammatory condition affecting the equine eye. This frustrating ailment, often impacting working horses and those with a history of trauma, is characterized by recurring episodes of ocular inflammation. The term "Monday morning sickness" arose due to its frequent recurrence following periods of rest or reduced workload, highlighting the link between activity and inflammation. ERU significantly impacts equine welfare and performance, necessitating prompt diagnosis and effective management. This response outlines the etiology, clinical presentation, diagnostic approaches, and practical management strategies for ERU.
Etiology and Pathogenesis
The exact etiology of ERU remains complex and multifactorial. It’s believed to be a delayed hypersensitivity reaction to *Leptospira* bacteria, often *Leptospira interrogans*. Initial infection, frequently subclinical, triggers an immune response. Subsequent exposure, coupled with factors like stress, changes in workload, and potentially environmental allergens, can trigger recurrent uveitis episodes.
- Role of *Leptospira*: Serological evidence points to a strong association, although isolation from the eye is rare.
- Environmental Factors: Dust, pollen, and fungal spores may act as adjuvants, exacerbating the inflammatory response.
- Trauma: Previous corneal or ocular trauma is a significant risk factor.
Clinical Signs
ERU presents with recurrent episodes of ocular inflammation, often asymmetrical. Signs can be acute and severe or more chronic and subtle.
- Acute Phase: Anhidrosis (lack of sweating), blepharospasm (eyelid closure), photophobia (light sensitivity), epiphora (excessive tearing), corneal edema, and pain.
- Chronic Phase: Glaucoma (increased intraocular pressure), cataracts, phthisis bulbi (shrinking of the eyeball), and blindness.
Diagnosis
Diagnosis relies on a combination of clinical signs, history, and diagnostic tests.
- Ophthalmologic Examination: Slit-lamp examination to assess corneal clarity, anterior chamber reaction, and posterior segment involvement.
- Intraocular Pressure Measurement: Tonometer to assess for glaucoma.
- Serological Testing: *Leptospira* antibody titers (MAT - microscopic agglutination test). A four-fold increase in titers between acute and convalescent samples supports the diagnosis, although results can be variable.
- Cytology: Analysis of aqueous humor or corneal scrapings can help rule out infectious causes.
Management
Management focuses on controlling inflammation and preventing recurrence. A tiered approach is typically employed.
- Acute Episodes: Systemic corticosteroids (prednisolone or dexamethasone) to rapidly reduce inflammation. Topical atropine to dilate the pupil and relieve pain.
- Maintenance Therapy: Long-term, low-dose oral corticosteroids or injectable depot forms (e.g., depot medroxyprogesterone acetate) to prevent recurrences.
- Environmental Modification: Reducing exposure to potential allergens and irritants.
- Supportive Care: Artificial tears to lubricate the cornea and prevent dryness.
| Management Phase | Medication | Rationale |
|---|---|---|
| Acute | Prednisolone/Dexamethasone (Systemic) | Rapidly reduce inflammation |
| Acute | Atropine (Topical) | Pupil dilation, pain relief |
| Maintenance | Depot Corticosteroids | Prevent recurrence |
Prognosis
ERU is a chronic condition requiring lifelong management. While individual episodes can be controlled, complete eradication is often impossible. Regular ophthalmic examinations are crucial to monitor for recurrence and complications.
Conclusion
Equine recurrent uveitis, or "Monday morning sickness," represents a significant challenge in equine ophthalmology. Understanding the complex interplay of *Leptospira* infection, environmental factors, and immune response is vital for effective management. A combination of acute anti-inflammatory measures, long-term maintenance therapy, and environmental modifications is necessary to control the disease and maintain ocular health. Continued research into preventative strategies and more targeted therapies remains critical for improving the prognosis for affected horses.
Answer Length
This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.